147 related articles for article (PubMed ID: 38562463)
1. Application of machine learning combined with population pharmacokinetics to improve individual prediction of vancomycin clearance in simulated adult patients.
Li G; Sun Y; Zhu L
Front Pharmacol; 2024; 15():1352113. PubMed ID: 38562463
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients.
Li ZR; Li RD; Niu WJ; Zheng XY; Wang ZX; Zhong MK; Qiu XY
J Clin Pharmacol; 2023 Mar; 63(3):314-325. PubMed ID: 36097320
[TBL] [Abstract][Full Text] [Related]
3. A Deep Learning-Based Approach for Prediction of Vancomycin Treatment Monitoring: Retrospective Study Among Patients With Critical Illness.
Kim D; Choi HS; Lee D; Kim M; Kim Y; Han SS; Heo Y; Park JH; Park J
JMIR Form Res; 2024 Mar; 8():e45202. PubMed ID: 38152042
[TBL] [Abstract][Full Text] [Related]
4. Improving prediction of tacrolimus concentration using a combination of population pharmacokinetic modeling and machine learning in chinese renal transplant recipients.
Wang YP; Lu XL; Shao K; Shi HQ; Zhou PJ; Chen B
Front Pharmacol; 2024; 15():1389271. PubMed ID: 38783953
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens.
Lin WW; Wu W; Jiao Z; Lin RF; Jiang CZ; Huang PF; Liu YW; Wang CL
Eur J Clin Pharmacol; 2016 Jan; 72(1):29-37. PubMed ID: 26423622
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance.
Chu Y; Luo Y; Ji S; Jiang M; Zhou B
J Infect Public Health; 2020 Jan; 13(1):68-74. PubMed ID: 31277936
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus pharmacokinetics in pediatric nephrotic syndrome: A combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction.
Huang Q; Lin X; Wang Y; Chen X; Zheng W; Zhong X; Shang D; Huang M; Gao X; Deng H; Li J; Zeng F; Mo X
Front Pharmacol; 2022; 13():942129. PubMed ID: 36457704
[No Abstract] [Full Text] [Related]
8. A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants.
Song L; He CY; Yin NG; Liu F; Jia YT; Liu Y
Oncotarget; 2017 Dec; 8(62):105211-105221. PubMed ID: 29285245
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
[TBL] [Abstract][Full Text] [Related]
10. Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction.
Tang BH; Guan Z; Allegaert K; Wu YE; Manolis E; Leroux S; Yao BF; Shi HY; Li X; Huang X; Wang WQ; Shen AD; Wang XL; Wang TY; Kou C; Xu HY; Zhou Y; Zheng Y; Hao GX; Xu BP; Thomson AH; Capparelli EV; Biran V; Simon N; Meibohm B; Lo YL; Marques R; Peris JE; Lutsar I; Saito J; Burggraaf J; Jacqz-Aigrain E; van den Anker J; Zhao W
Clin Pharmacokinet; 2021 Nov; 60(11):1435-1448. PubMed ID: 34041714
[TBL] [Abstract][Full Text] [Related]
11. Establishment and application of population pharmacokinetics model of vancomycin in infants with meningitis.
Xu J; Zhu Y; Niu P; Liu Y; Li D; Jiang L; Shi D
Pediatr Neonatol; 2022 Jan; 63(1):57-65. PubMed ID: 34544677
[TBL] [Abstract][Full Text] [Related]
12. Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.
Yu YX; Lu J; Lu HD; Li L; Li JJ; Shi L; Duan LF; Zhuang ZW; Xue SD; Shen Y; Tang L
Eur J Hosp Pharm; 2022 Mar; 29(e1):e6-e14. PubMed ID: 33414258
[TBL] [Abstract][Full Text] [Related]
13. Dosage optimization of tacrolimus based on the glucocorticoid dose and pharmacogenetics in adult patients with systemic lupus erythematosus.
Wang CB; Zhang YJ; Zhao MM; Zhao L
Int Immunopharmacol; 2023 Nov; 124(Pt A):110866. PubMed ID: 37678026
[TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies.
Wang H; Huang L; Wang J; Ni Y; Zhu Z; Gao P; Hu Y; Zhang L; Yang J; Fang L
Pharmacotherapy; 2020 Dec; 40(12):1201-1209. PubMed ID: 33070357
[TBL] [Abstract][Full Text] [Related]
15. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
Rao Z; Guo SM; Wei YM
Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C and/or creatinine-based estimated glomerular filtration rate for prediction of vancomycin clearance in long-stay critically ill patients with persistent inflammation, immunosuppression and catabolism syndrome (PICS): a population pharmacokinetics analysis.
Huang J; Wang X; Hao C; Yang W; Zhang W; Liu J; Qu H
Intern Emerg Med; 2021 Oct; 16(7):1883-1893. PubMed ID: 33728578
[TBL] [Abstract][Full Text] [Related]
17. External validation of population pharmacokinetic models of vancomycin in postoperative neurosurgical patients.
Wei S; Chen J; Zhao Z; Mei S
Eur J Clin Pharmacol; 2023 Aug; 79(8):1031-1042. PubMed ID: 37261482
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin in neonatal sepsis: predictive performance of a Chinese neonatal population pharmacokinetic model and clinical efficacy evaluation.
Weng XH; Zhu CQ; Duan LF; Li L; Yang ZM; Wang SN; Cai Y; Li JJ; Yu YX; Feng ZT; Tang L
Eur J Hosp Pharm; 2022 Mar; 29(2):101-108. PubMed ID: 33472817
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of topiramate in Chinese children with epilepsy.
Wei S; Li X; Zhang Q; Wu H; Wu Y; Zhao Z; Mei S; Feng W
Eur J Clin Pharmacol; 2023 Oct; 79(10):1401-1415. PubMed ID: 37597080
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of vancomycin population pharmacokinetics model in patients with hematological diseases and neutropenia.
Fu X; Lin L; Huang L; Guo L
Biopharm Drug Dispos; 2021 Nov; 42(9):427-434. PubMed ID: 34651308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
